BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1996575)

  • 1. Plasma terminal complement complexes in acute poststreptococcal glomerulonephritis.
    Matsell DG; Roy S; Tamerius JD; Morrow PR; Kolb WP; Wyatt RJ
    Am J Kidney Dis; 1991 Mar; 17(3):311-6. PubMed ID: 1996575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terminal complement complexes in acute poststreptococcal glomerulonephritis.
    Matsell DG; Wyatt RJ; Gaber LW
    Pediatr Nephrol; 1994 Dec; 8(6):671-6. PubMed ID: 7696103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease in mean platelet survival time in acute poststreptococcal glomerulonephritis (APSGN).
    Mezzano S; Lopez MI; Olavarria F; Ardiles L; Mezzano D
    Clin Nephrol; 1990 Oct; 34(4):147-51. PubMed ID: 2257699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial studies of circulating immune complexes in poststreptococcal glomerulonephritis.
    Lin CY
    Pediatrics; 1982 Nov; 70(5):725-7. PubMed ID: 7133824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating immune complexes and serum immunoglobulins in acute poststreptococcal glomerulonephritis.
    Rodríguez-Iturbe B; Carr RI; García R; Rabideau D; Rubio L; McIntosh RM
    Clin Nephrol; 1980 Jan; 13(1):1-4. PubMed ID: 7363511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Terminal complement complex (TTC) levels in plasma and urine from glomerular diseases: enzyme-linked immunosorbent assay (ELISA) using monoclonal antibody against neoantigens of TCC].
    Kusunoki Y
    Hokkaido Igaku Zasshi; 1990 Jan; 65(1):74-85. PubMed ID: 2328949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of an autologous immune complex pathogenic mechanism in acute poststreptococcal glomerulonephritis.
    McIntosh RM; García R; Rubio L; Rabideau D; Allen JE; Carr RI; Rodríguez-Iturbe B
    Kidney Int; 1978 Nov; 14(5):501-10. PubMed ID: 750695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of the detection of circulating immune complexes in acute diffuse poststreptococcal glomerulonephritis].
    Sesso Rde C; Alves MA; Nishida SK; Ramos OL; Pereira AB
    AMB Rev Assoc Med Bras; 1987; 33(3-4):43-5. PubMed ID: 3501138
    [No Abstract]   [Full Text] [Related]  

  • 9. Autoantibodies against complement C1q in acute post-streptococcal glomerulonephritis.
    Kozyro I; Korosteleva L; Chernoshej D; Danner D; Sukalo A; Trendelenburg M
    Clin Immunol; 2008 Sep; 128(3):409-14. PubMed ID: 18544473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy.
    Corvillo F; Bravo García-Morato M; Nozal P; Garrido S; Tortajada A; Rodríguez de Córdoba S; López-Trascasa M
    Clin Exp Immunol; 2016 Apr; 184(1):118-25. PubMed ID: 26660535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of circulating immune complexes in patients with acute poststreptococcal glomerulonephritis and in patients with streptococcal impetigo.
    Mezzano S; Olavarría F; Ardiles L; López MI
    Clin Nephrol; 1986 Aug; 26(2):61-5. PubMed ID: 3530567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum C3 levels in acute poststreptococcal glomerulonephritis.
    Sul JH; Kim PK; Yun DJ
    Yonsei Med J; 1979; 20(2):149-54. PubMed ID: 552189
    [No Abstract]   [Full Text] [Related]  

  • 13. An adult with acute poststreptococcal glomerulonephritis complicated by hemolytic uremic syndrome and nephrotic syndrome.
    Izumi T; Hyodo T; Kikuchi Y; Imakiire T; Ikenoue T; Suzuki S; Yoshizawa N; Miura S
    Am J Kidney Dis; 2005 Oct; 46(4):e59-63. PubMed ID: 16183409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes and complement levels in relation to the clinical presentation of Nigerian children with acute poststreptococcal glomerulonephritis.
    Onyewotu II; Mee J
    J Clin Pathol; 1978 Sep; 31(9):817-22. PubMed ID: 711910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes in children with acute poststreptococcal glomerulonephritis.
    Franco S; Moalem T; Becker M; Sadan N; Klajman A
    Isr J Med Sci; 1980 May; 16(5):357-60. PubMed ID: 7399865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of SC5b--9 complement complex in plasma and synovial fluid of patients with rheumatic disease.
    Rus V; Malide D; Boloşiu HD; Parasca I; Duţu AL
    Med Interne; 1990; 28(4):305-10. PubMed ID: 2100875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective phagocyte adherence in acute poststreptococcal glomerulonephritis: clinical and laboratory observations.
    Ruley EJ; Huang SW; Plaut J; Morris N
    J Pediatr; 1976 Nov; 89(5):748-54. PubMed ID: 978322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C3 mesangial proliferative glomerulonephritis--an evaluation of acute poststreptococcal glomerulonephritis?
    Deliyska B; Minkova V; Nikolov D; Tishkov I
    Clin Nephrol; 1997 Dec; 48(6):390. PubMed ID: 9518184
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of the terminal fluid-phase complement complex, SC5b-9, in the plasma of patients with insulin-dependent (type I) diabetes mellitus. Relation to increased urinary albumin excretion and plasma von Willebrand factor.
    Triolo G; Giardina E; Casiglia D; Scarantino G; Bompiani GD
    Clin Exp Immunol; 1991 Apr; 84(1):53-8. PubMed ID: 2015712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum immunoglobulins in acute poststreptococcal glomerulonephritis.
    Gómez-Gómez M; Santos-Atherton D; Vargas-Rosendo R; Martínez Cairo-Cueto S; Alanis-Chavarría F; Tudón-Garcés H
    Arch Invest Med (Mex); 1985; 16(1):99-110. PubMed ID: 4015301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.